Skip Navigation LinksHome > August 2012 - Volume 34 - Issue 6 > Severe Transient Left Ventricular Pseudohypertrophy During T...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318257a4cb
Clinical and Laboratory Observations

Severe Transient Left Ventricular Pseudohypertrophy During Treatment of Hemophagocytic Lymphohistiocytosis: A Case Report

Kuzmanovic, Milos MD; Pasic, Srdjan MD, PhD; Prijic, Sergej MD; Jovanovic, Ankica MD; Kosutic, Jovan MD, PhD

Collapse Box


Background: An association between hemophagocytic lymphohistiocytosis (HLH) and severe transient left ventricular (LV) hypertrophy has not been described to date. Possible explanations, including etoposide toxicity, are discussed.

Observation: A 2-month-old male infant with HLH was treated according to the HLH-2004 protocol. Initial cardiac evaluation was within normal limits. During the second month of therapy, a heart murmur was discovered; electrocardiogram demonstrated signs of LV hypertrophy, and echocardiogram confirmed the presence of thickness of LV walls. This complication was transient: clinical findings, echocardiogram, and electrocardiogram recorded 6 months afterward were all within normal limits.

Conclusions: The case suggests the need for close echocardiographic monitoring during HLH treatment.

Copyright © 2012 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.